March 20, 2017
Pharmacosmos has signed up as sponsor at the 9th
European Symposium of Porcine Health Management. in Prague/Czech
Republic - from the 3rd - 5th of May
We welcome new and existing Uniferon customers to visit our
exhibition where we would be pleased to inform you about Uniferon
and discuss optimized anaemia care.
Visit us at our Exhibition stand S5. Find
the position on the image below.
For additional information about ESPHM 2017, please
Click to enlarge
Uniferon 200 is an iron supplement
that adds value to your business by promoting better health and
faster growth in your piglets. Manufactured by Pharmacosmos,
Uniferon 200 combines the benefits of simple, fast administration
with all-natural, high efficacy ingredients.
Pharmacosmos is dedicated to developing and marketing
industry-leading iron deficiency treatments for both humans and
animals. We focus on improving treatment options by staying on top
of industry best practices. A privately-owned company with an
extensive network of partners, Pharmacosmos operates in more than
50 countries across Europe, the Americas and Asia.
Headquartered in Denmark, Pharmacosmos is a family-owned,
international healthcare company with more than 50 years of
innovation and leadership in iron- and carbohydrate-based
treatments and solutions for human and animal use.
A research-based company, its ongoing R&D programme focuses
on improving the lives of patients with iron deficiency with or
without anaemia. More than 1 billion people live with iron
deficiency anaemia and it is the leading cause of death for an
estimated 180,000 people every year. This makes it one of the
largest global health challenges of our time.
Pharmacosmos has subsidiaries in the Nordics, the UK and the US
and its products are marketed in more than 80 countries across the
world. Its manufacturing facilities are approved, among others, by
the Danish Medicines Agency and the US FDA.